SI-BONE reports record Q4 2025 revenue of $56.3M (+15% YoY), positive adjusted EBITDA, and issues 2026 guidance

SI-BONE, Inc.

2025-FY EPS reported -$0.44 vs consensus -$0.13 ▼ miss (-242.4%)

Q4 2025 worldwide revenue $56.3M, up 15% YoY; FY2025 revenue $200.9M, up 20.2% YoY.
Q4 net loss improved 63.3% to $1.6M ($0.04/diluted share); positive adjusted EBITDA $5.1M (vs $1.9M).
FY2025 net loss $18.9M vs $30.9M; positive adjusted EBITDA $8.9M (vs –$5.1M).
2026 revenue guidance $228.5M–$232.5M (~14%–16% YoY growth); expects increased adjusted EBITDA.
CFO Anshul Maheshwari appointed additional role as COO effective Feb 22, 2026.

item 1.01 item 2.02 item 5.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

SI-BONE, Inc. entered into Lease with Orchard Commons, LLC (effective 2026-02-20).

Action: entry
Agreement: lease
Counterparty: Orchard Commons, LLC
Effective: 2026-02-20

Exact text from the filing

On February 20, 2026, SI-BONE, Inc. (the “Company”) and Orchard Commons, LLC (the “Landlord”) entered into a lease agreement (the “Lease”), pursuant to which the Company will lease approximately 50,485 square feet of space located at 88 West Plumeria Drive, San Jose, California 95134 (the “Premises”).

View on SEC.gov

292 material agreements filed in the last 30 days. Browse all material agreements →

SI-BONE, Inc. filing history →

Source: SEC EDGAR

accession 0001459839-26-000022

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.